SavedAdd your journal

Journals / Klinik Psikofarmakoloji Bülteni / 2015 / Cilt: 25 - Sayı: 3

Escitalopram and Intermenstrual Vaginal Bleeding: A Probable Association

Erbil KARAMAN
Derya TURELİ
Yasemin KARAMAN
Abdullah YİLDİRİM
Pages
317–318
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

KARAMAN, E., TURELİ, D., KARAMAN, Y., YİLDİRİM, A. (2022). Escitalopram and Intermenstrual Vaginal Bleeding: A Probable Association. Klinik Psikofarmakoloji Bülteni, Cilt: 25 - Sayı: 3, 317–318. https://ajindex.com/articles/573958

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Lundbeck Canada Inc. Cipralex (escitalopram oxalate tablets) product monograph. Montreal, Canada; 2012.
  2. Weinrieb RM, Auriacombe M, Lynch KG, Lewis JD. Selective serotonin re-uptake inhibitors and the risk of bleeding. Expert Opin Drug Saf 2005;4(2):337-44. [CrossRef] de Abajo FJ. Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients. Drugs Aging 2011;28(5):345-67. [CrossRef] Steiner M, Lamont J, Steinberg S, Stewart D, Reid R, Steiner D. Effect of fluoxetine on menstrual cycle length in women with premenstrual dysphoria. Obstet Gynecol 1997;90:590-5. [CrossRef] Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30(2):239-45. [CrossRef]